Smart biomaterials and nanotechnology

New tools for more precise drug delivery systems Kimbelery Pardo – Marketing and Business Development Analyst The pharmaceutical industry is undergoing a period of profound transformation driven by the convergence of materials science, biology, and technology. In this context, smart biomaterials and nanotechnology are emerging as key tools for the [...]

Read More

Ethical Alternatives to Animal Experimentation: Advances in In Vitro Models and Their Relevance for Transdermal System Development

In recent years, the pharmaceutical and life sciences industry has intensified its search for alternatives to animal experimentation. This trend responds to three simultaneous pressures: growing concern for animal welfare, scientific doubts about the validity of extrapolating animal data to humans, and the increasing availability of alternative methodologies yielding more [...]

Read More

Evolution of the Transdermal Market: Mergers, Diversification, and Business Opportunities in a Transforming Segment

Transdermal patches have come a long way since their introduction in 1979. However, unlike other pharmaceutical forms, they never achieved massive market penetration: between 2015 and 2022, the FDA approved only 84 transdermal patches out of a total of 7,239 generic products, representing just 1.2% of the total. The reason [...]

Read More